Last Updated: October 2, 2026

Patent: 10,696,750

✉ Email this page to a colleague

Summary for Patent: 10,696,750

Title:	Multi-specific monoclonal antibodies
Abstract:	The present invention is relevant to the generation of multi-specific antibodies, antibodies that are distinguished by their ability to bind to multiple antigens with specificity and with affinity. In particular, the present invention is related to bi-specific antibodies.
Inventor(s):	Gerhard Frey, Hwai Wen Chang, Jay M. Short
Assignee:	Bioatla Inc
Application Number:	US16/264,028
Patent Claims:	see list of patent claims

Details for Patent 10,696,750

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Valeant Pharmaceuticals Luxembourg S.à.r.l.	SILIQ	brodalumab	Injection	761032	February 15, 2017	10,696,750	2039-01-31
Bausch Health Ireland, Limited	SILIQ	brodalumab	Injection	761032	15-Feb-17	10,696,750	2039-01-31
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,696,750

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2013170168	⤷ Start Trial
United States of America	2015252119	⤷ Start Trial
United States of America	2018237543	⤷ Start Trial
United States of America	2019153120	⤷ Start Trial
United States of America	9969813	⤷ Start Trial
Mexico	2014013590	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.